The Client Is Receiving a Drug in a Phase I

The client is receiving a drug in a phase I clinical trial. Regarding the type of malignancy for which the client is being treated, the nurse makes the assumption that the cancer

A) and its treatment are not covered by the client's insurance.
B) is limited in size and virulence.
C) is not following the expected disease course.
D) will not respond to other known treatments for cancer.